NDC Package 70710-1723-5 Carbidopa And Levodopa

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

70710-1723-5

Package Description:

500 TABLET in 1 BOTTLE

Product Code:

70710-1723

Proprietary Name:

Carbidopa And Levodopa

Usage Information:

Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa.Carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa.

11-Digit NDC Billing Format:

70710172305

Labeler Name:

Zydus Pharmaceuticals Usa Inc.

Sample Package:

FDA Application Number:

ANDA215999

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

08-24-2024

End Marketing Date:

03-27-2025

Listing Expiration Date:

03-27-2025

Exclude Flag:

Code Structure:

70710 - Zydus Pharmaceuticals Usa Inc.
- 70710-1723 - Carbidopa And Levodopa
  - 70710-1723-5 - 500 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
70710-1723-0	1000 TABLET in 1 BOTTLE
70710-1723-1	100 TABLET in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70710-1723-5?

The NDC Packaged Code 70710-1723-5 is assigned to a package of 500 tablet in 1 bottle of Carbidopa And Levodopa, labeled by Zydus Pharmaceuticals Usa Inc.. The product's dosage form is and is administered via form.

Is NDC 70710-1723 included in the NDC Directory?

No, Carbidopa And Levodopa with product code 70710-1723 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Zydus Pharmaceuticals Usa Inc. on August 24, 2024 and its listing in the NDC Directory is set to expire on March 27, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70710-1723-5?

The 11-digit format is 70710172305. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-4-1	70710-1723-5	5-4-2	70710-1723-05

Table of Contents